BMC Cardiovascular Disorders

official impact factor 2.02

Open Access Highly Access Research article

Duration of clopidogrel treatment and risk of mortality and recurrent myocardial infarction among 11 680 patients with myocardial infarction treated with percutaneous coronary intervention: a cohort study

Rikke Sørensen1*, Steen Z Abildstrom2,3, Peter Weeke1, Emil L Fosbøl, Fredrik Folke1, Morten L Hansen1, Peter R Hansen1, Jan K Madsen1, Ulrik Abildgaard1, Lars Køber4, Henrik E Poulsen5,6, Christian Torp-Pedersen1 and Gunnar H Gislason1

Author Affiliations

1 Department of Cardiology, Copenhagen University Hospital Gentofte, Niels Andersens Vej 65, 2900 Hellerup, Denmark

2 Cardiovascular Research Unit, Department of Internal Medicine, Copenhagen University Hospital Glostrup, Ndr. Ringvej 57, 2600 Glostrup, Denmark

3 National Institute of Public Health, University of Southern Denmark, Øster Farimagsgade 5A, second floor, 1353 København K, Denmark

4 The Heart Centre, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark

5 Department of Clinical Pharmacology, Copenhagen University Hospital Bispebjerg, Bispebjerg Bakke 23, 2400 København NV, Denmark

6 Laboratory of Clinical Pharmacology, Q7642, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100 København Ø, Denmark

For all author emails, please log on.

BMC Cardiovascular Disorders 2010, 10:6 doi:10.1186/1471-2261-10-6

Published: 29 January 2010

Additional files

Additional file 1:

Baseline characteristics. This file contains baseline information (year of admission, sex, age, co-morbidity, concomitant medical treatment). The patients are stratified according to PCI status.

Format: PDF Size: 11KB Download file

This file can be viewed with: Adobe Acrobat Reader

Open Data